ImmuCell reports 18% sales growth in Q2 2025

Go back to ImmuCell reports 18% sales growth in Q2 2025
Immucell Corp (NASDAQ: ICCC) Delayed: 10.06 -0.03 (0.3%)
Previous Close $10.09    52 Week High $8.29 
Open $10.09    52 Week Low $4.99 
Day High $10.49    P/E 125.75 
Day Low $10.05    EPS $0.08 
Volume 11,131